Cystic fibrosis is a complicated disease. As patients, we are taught that mutations in our…
Reid D'Amico
At the time of writing this column, Reid had started his PhD in biomedical engineering at Vanderbilt University. He uses an engineering approach to research pulmonary hypertension. Reid has CF, and finds much of his drive by experiencing both the research and patient aspects of cystic fibrosis. Reid has also served as a director at the U.S. Adult Cystic Fibrosis Association.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Reid D'Amico
Some resolutions are common to all: Work out more, eat healthier, make grandiose changes, or check off an…
Struggling to Let Others In
Cystic fibrosis (CF) is unpredictable. Some days I feel like I can run my fastest personal mile,…
In August, Allergan pharmaceuticals announced in a letter to healthcare professionals that it would be restructuring…
Cystic fibrosis (CF) is horrible. Say it again for the people in the back: It is horrible. To…
Chronic pulmonary infections are a hallmark of lung disease in patients with cystic fibrosis. Due to the…
Many of us with pre-existing conditions have been following the news about the future of healthcare in…
College is expensive. And when the cost of tuition comes on top of the cost of living with cystic fibrosis,…
Perhaps one of the most exciting parts of being both a patient and a scientist with CF is seeing just…
Last week, I had the opportunity to accompany Vertex Pharmaceuticals as the Tennessee State Senate declared May 2017 Cystic Fibrosis…